Be a Smart Investor
Monday, April 15, 2019
Catalent reportedly to buy Paragon Bioservices for $1.2 billion
Catalent said on Monday it would buy privately held gene therapy-focused Paragon Bioservices Inc in an all-cash deal for $1.2 billion.
from Deals and IPOs https://cnb.cx/2GnAf9q
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment